245 related articles for article (PubMed ID: 15865881)
21. Predictors of survival and effect of short (40 Gy) or standard-course (60 Gy) irradiation plus concomitant temozolomide in elderly patients with glioblastoma: a multicenter retrospective study of AINO (Italian Association of Neuro-Oncology).
Lombardi G; Pace A; Pasqualetti F; Rizzato S; Faedi M; Anghileri E; Nicolotto E; Bazzoli E; Bellu L; Villani V; Fabi A; Ferrazza P; Gurrieri L; Dall'Agata M; Eoli M; Della Puppa A; Pambuku A; D'Avella D; Berti F; Rudà R; Zagonel V
J Neurooncol; 2015 Nov; 125(2):359-67. PubMed ID: 26423801
[TBL] [Abstract][Full Text] [Related]
22. A concurrent ultra-fractionated radiation therapy and temozolomide treatment: A promising therapy for newly diagnosed, inoperable glioblastoma.
Beauchesne P; Quillien V; Faure G; Bernier V; Noel G; Quetin P; Gorlia T; Carnin C; Pedeux R
Int J Cancer; 2016 Mar; 138(6):1538-44. PubMed ID: 26501997
[TBL] [Abstract][Full Text] [Related]
23. Combined modality treatment of glioblastoma multiforme: the role of temozolomide.
Nieder C; Adam M; Grosu AL
Rev Recent Clin Trials; 2006 Jan; 1(1):43-51. PubMed ID: 18393779
[TBL] [Abstract][Full Text] [Related]
24. Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy.
Noel G; Huchet A; Feuvret L; Maire JP; Verrelle P; Le Rhun E; Aumont M; Thillays F; Sunyach MP; Henzen C; Missohou F; de Crevoisier R; Bondiau PY; Collin P; Durando X; Truc G; Kerr C; Bernier V; Clavier JB; Atlani D; D'Hombres A; Vinchon-Petit S; Lagrange JL; Taillandier L
J Neurooncol; 2012 Aug; 109(1):167-75. PubMed ID: 22660920
[TBL] [Abstract][Full Text] [Related]
25. A small proportion of glioblastoma patients are probably eligible for concomitant/adjuvant temozolomide.
O'Toole L; Khanduri S; Gerrard GE
Clin Oncol (R Coll Radiol); 2007 May; 19(4):269. PubMed ID: 17433972
[No Abstract] [Full Text] [Related]
26. A survival analysis of GBM patients in the West of Scotland pre- and post-introduction of the Stupp regime.
Teo M; Martin S; Owusu-Agyemang K; Nowicki S; Clark B; Mackinnon M; Stewart W; Paul J; St George J
Br J Neurosurg; 2014 Jun; 28(3):351-5. PubMed ID: 24111708
[TBL] [Abstract][Full Text] [Related]
27. Patterns of care and outcome for patients with glioblastoma diagnosed during 2008-2010 in Spain.
Graus F; Bruna J; Pardo J; Escudero D; Vilas D; Barceló I; Brell M; Pascual C; Crespo JA; Erro E; García-Romero JC; Estela J; Martino J; García-Castaño A; Mata E; Lema M; Gelabert M; Fuentes R; Pérez P; Manzano A; Aguas J; Belenguer A; Simón A; Henríquez I; Murcia M; Vivanco R; Rojas-Marcos I; Muñoz-Carmona D; Navas I; de Andrés P; Mas G; Gil M; Verger E
Neuro Oncol; 2013 Jun; 15(6):797-805. PubMed ID: 23460319
[TBL] [Abstract][Full Text] [Related]
28. Potential usefulness of radiosensitizers in glioblastoma.
Harasaki Y; Waziri A
Neurosurg Clin N Am; 2012 Jul; 23(3):429-37. PubMed ID: 22748655
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of temozolomide treatment used at the same time with radiotherapy and adjuvant temozolomide; concomitant therapy of glioblastoma multiforme: multivariate analysis and other prognostic factors.
Birol Sarica F; Tufan K; Cekinmez M; Sen O; Cem Onal H; Mertsoylu H; Topkan E; Pehlivan B; Erdogan B; Nur Altinors M
J Neurosurg Sci; 2010 Mar; 54(1):7-19. PubMed ID: 20436394
[TBL] [Abstract][Full Text] [Related]
30. Influence of incidental radiation dose in the subventricular zone on survival in patients with glioblastoma multiforme treated with surgery, radiotherapy, and temozolomide.
Foro Arnalot P; Pera O; Rodriguez N; Sanz X; Reig A; Membrive I; Ortiz A; Granados R; Algara M
Clin Transl Oncol; 2017 Oct; 19(10):1225-1231. PubMed ID: 28389881
[TBL] [Abstract][Full Text] [Related]
31. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.
Stupp R; Hegi ME; Mason WP; van den Bent MJ; Taphoorn MJ; Janzer RC; Ludwin SK; Allgeier A; Fisher B; Belanger K; Hau P; Brandes AA; Gijtenbeek J; Marosi C; Vecht CJ; Mokhtari K; Wesseling P; Villa S; Eisenhauer E; Gorlia T; Weller M; Lacombe D; Cairncross JG; Mirimanoff RO; ;
Lancet Oncol; 2009 May; 10(5):459-66. PubMed ID: 19269895
[TBL] [Abstract][Full Text] [Related]
32. Prospective study of carmustine wafers in combination with 6-month metronomic temozolomide and radiation therapy in newly diagnosed glioblastoma: preliminary results.
Salmaggi A; Milanesi I; Silvani A; Gaviani P; Marchetti M; Fariselli L; Solero CL; Maccagnano C; Casali C; Guzzetti S; Pollo B; Ciusani E; Dimeco F
J Neurosurg; 2013 Apr; 118(4):821-9. PubMed ID: 23350777
[TBL] [Abstract][Full Text] [Related]
33. Toxicity and survival in primary glioblastoma patients treated with concomitant plus adjuvant temozolomide versus adjuvant temozolomide: results of a single-institution, retrospective, matched-pair analysis.
Gutenberg A; Bock HC; Reifenberger G; Brück W; Giese A
Acta Neurochir (Wien); 2013 Mar; 155(3):429-35. PubMed ID: 23254891
[TBL] [Abstract][Full Text] [Related]
34. Standard (60 Gy) or short-course (40 Gy) irradiation plus concomitant and adjuvant temozolomide for elderly patients with glioblastoma: a propensity-matched analysis.
Minniti G; Scaringi C; Lanzetta G; Terrenato I; Esposito V; Arcella A; Pace A; Giangaspero F; Bozzao A; Enrici RM
Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):109-15. PubMed ID: 25442339
[TBL] [Abstract][Full Text] [Related]
35. Commentary on Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial (Lancet Oncol. 2009;10:459-466).
Linz U
Cancer; 2010 Apr; 116(8):1844-6. PubMed ID: 20151424
[TBL] [Abstract][Full Text] [Related]
36. Validation of the Effectiveness and Safety of Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas: 10-year Experience of a Single Institution.
Joo JD; Kim H; Kim YH; Han JH; Kim CY
J Korean Med Sci; 2015 Nov; 30(11):1597-603. PubMed ID: 26539003
[TBL] [Abstract][Full Text] [Related]
37. Radio-chemotherapy with temozolomide in elderly patients with glioblastoma. A mono-institutional experience.
Pasqualetti F; Ferrazza P; Cocuzza P; Fatigante L; Pasqualetti G; Fabbrini MG; Monzani F
Anticancer Res; 2014 Aug; 34(8):4281-5. PubMed ID: 25075059
[TBL] [Abstract][Full Text] [Related]
38. Analysis of Treatment Tolerance and Factors Associated with Overall Survival in Elderly Patients with Glioblastoma.
Zhang C; Wang X; Hao S; Su Z; Zhang P; Li Y; Song G; Yu L; Wang J; Ji N; Xie J; Gao Z
World Neurosurg; 2016 Nov; 95():77-84. PubMed ID: 27485530
[TBL] [Abstract][Full Text] [Related]
39. Outcome of conventional treatment and prognostic factor in elderly glioblastoma patients.
Oh SW; Jee TK; Kong DS; Nam DH; Lee JI; Seol HJ
Acta Neurochir (Wien); 2014 Apr; 156(4):641-51. PubMed ID: 24553726
[TBL] [Abstract][Full Text] [Related]
40. Change in platelet levels during radiotherapy with concurrent and adjuvant temozolomide for the treatment of glioblastoma: a novel prognostic factor for survival.
Williams M; Liu ZW; Woolf D; Hargreaves S; Michalarea V; Menashy R; Kooner I; Wilson E
J Cancer Res Clin Oncol; 2012 Oct; 138(10):1683-8. PubMed ID: 22644996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]